GLIOMA GLIOBLASTOMA MULTIFORME
Clinical trials for GLIOMA GLIOBLASTOMA MULTIFORME explained in plain language.
Never miss a new study
Get alerted when new GLIOMA GLIOBLASTOMA MULTIFORME trials appear
Sign up with your email to follow new studies for GLIOMA GLIOBLASTOMA MULTIFORME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat cancers: experimental drug targets MTAP-loss tumors
Disease control Recruiting nowThis study tests a new oral drug, TNG456, in people with advanced solid tumors that have lost a gene called MTAP. The drug works by blocking a protein (PRMT5) that these tumors need to grow. The study has two parts: first, finding the safest dose of TNG456 alone or with abemacicl…
Matched conditions: GLIOMA GLIOBLASTOMA MULTIFORME
Phase: PHASE1, PHASE2 • Sponsor: Tango Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 00:32 UTC
-
New MRI technique could supercharge brain tumor treatment
Disease control Recruiting nowThis study tests a more precise way to place electrodes on the scalp for glioblastoma patients receiving Optune therapy, which uses electrical fields to kill cancer cells. By using advanced MRI to map the full extent of the tumor, researchers hope to deliver a stronger dose to th…
Matched conditions: GLIOMA GLIOBLASTOMA MULTIFORME
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 11, 2026 20:37 UTC